Professor Ketan Dhatariya will explore how the sudden unavailability of GLP-1s has impacted diabetes care during a webinar discussion next month.
The event will be held during Hypo Awareness Week on Tuesday, September 12, between 2pm and 3pm.
It will discuss how the shortage has led to a shift in prescribing and how people on these drugs for diabetes need to be moved to alternative agents.
Professor Dhatariya, Consultant in Diabetes and Endocrinology, is hosting the event, which will go through some of the information that ABCD and PCDS has suggested to minimise the impact of these changes.
Entitled ‘Why unavailability of GLP-1 receptor analogues has a knock-on effect, raising the risk of hypoglycaemia’, the webinar is only available to diabetes teams who have registered for Hypo Awareness Week.
Hypo Awareness Week 2023 is taking place across the UK and Ireland from Monday, September 11 to Friday, September 17.
The national campaign gives the diabetes community the chance to discuss, and roll out education about, hypoglycaemia across UK hospitals and primary care settings.
If you would like to attend the event, register for Hypo Awareness Week by emailing email@example.com with the following information:
Lead organiser’s name
Name of trust/organisation
Number and names of participating sites.
Once registered, you will receive an online resource pack and an invitation to sign up for the webinar.
This project has been funded by GlucoRx, MySugarWatch®️, Sanofi and Vertex Pharmaceuticals which have had no input into any arrangements or content.